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Summary 
Celiac disease (CD) is most probably an immunological disease, precipitated in susceptible individuals 
by ingestion of wheat gliadin and related proteins from other cereals. The disease shows a strong 
human HLA association predominantly to the c/s or trans encoded HLA-DQ(o~I*O5OI,fll*0201) 
(DQ2) heterodimer. T cell recognition of gliadin presented by this DQ heterodimer may thus 
be of immunopathogenic importance in CD. We therefore challenged small intestinal biopsies 
from adult CD patients on a gluten-free diet in vitro with gluten (containing both gliadin and 
other wheat proteins), and isolated activated CD25 + T cells. Polyclonal T cell lines and a panel 
of T cell clones recognizing gluten were established. They recognized the gliadin moiety of gluten, 
but not proteins from other cereals. Inhibition studies with anti-HLA antibodies demonstrated 
predominant antigen presentation by HLA-DQ molecules. The main antigen-presenting molecule 
was established to be the CD-associated DQ(oel*0501, fl1"0201) heterodimer. The gluten-reactive 
T  cell clones were CD4 +, CD8-,  and carried diverse combinations of T  cell receptor (TCR) 
Vc~ and Vfl chains. The findings suggest preferential mucosal presentation of gluten-derived 
peptides by HLA-DQ(c~I*OSO1,BI*0201)  in CD,  which may explain the HLA association. 
C 
eliac disease (CD) 1 is a disorder of the small intestine, 
characterized by crypt-cell hyperplasia and villous at- 
rophy (1, 2).  As a result, mild to severe malabsorption and 
diarrhea are often found. The disease is precipitated in sus- 
ceptible individuals by ingestion of cereal proteins. In partic- 
ular, wheat gluten, but also rye, and to a lesser extent, barley 
and oat, may cause disease.  Once these nutrients are with- 
drawn from the diet, the intestinal morphology will normalize. 
CD is most probably an immunological disease (1-3), and 
shows a well-defined HLA association. We previously found 
that 93 of 94 Norwegian CD patients carried the DQAI*0501 
and DQBI*0201 genes in cis or trans position (4), which en- 
code the DQ(oll*O501,f11*0201)  heterodimer (5). This strong 
association is found in most patient populations (6, 7). How- 
ever, the link between the immunopathology and the HLA 
association has not been elucidated, since gluten-reactive T 
cells from the mucosa of CD patients have previously not 
been reported (8). 
Challenge of treated CD patients (i.e.,  on a gluten-free 
diet) with gluten induces a systemic and mucosal immune 
activation (9-12). When small intestinal biopsies  from CD 
patients  on a gluten-free diet are challenged ex vivo with 
gluten, CD4 + T cells in the lamina propria are activated and 
express CD25 (IL-2 receptor L chain) (13). Similar findings 
are not made in biopsies  from healthy individuals. Here we 
show that such activated T cells mainly recognize gluten when 
presented by the HLA-DQ(c~I*O501,BI*0201)  heterodimer. 
The results suggest that an important feature of celiac dis- 
ease may be presentation,  at the site of the disease lesion, 
of gluten-derived peptides by the CD-associated HLA-DQ 
heterodimer itself. 
t Abbreviations used in this paper: B-LCL, B lymphoblastoid cell line; CD, 
celiac disease; IHWS, International  Histocompatibility  Workshop; TCC, 
T  cell clone. 
Materials and Methods 
Patients.  Biopsies  were taken from eight CD patients, two with 
untreated disease and six on a gluten-free diet. The diagnosis was 
based on typical mucosal lesions with crypt hypertrophy, villous 
atrophy, and an increased number of intraepithelial lymphocytes. 
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i.e., they carried the DQ(al*0501,fll*0201) heterodimer. All treated 
CD patients improved clinically  on a gluten-free diet. By the time 
biopsies were taken for the present study, formalin-fixed  biopsies 
were H-E stained and evaluated  by light microscopy.  Some but not 
all patients had shown complete normalization on a presumptive 
gluten-free diet. Patients controls (n =  5) had clinical symptoms 
partly suggestive  of  CD, but their small  intestinal mucosa  was histo- 
logically normal. 
Antigens and Peptides.  Cereal  protein antigens were prepared 
based on their solubility in dilute acids and alcohol (14). Flour was 
defatted and water-soluble proteins extracted by washing twice in 
water-saturated n-butanol. Wheat gluten (containing both gliadins 
and glutenins) and corresponding proteins from other cereals were 
extracted with 0.01 M acetic acid, whereas gliadin was extracted 
with 70% (vol/vol) ethanol. Trade gluten (ICN Nutritional Bio- 
chemicals, Cleveland, OH) or gliadin (Sigma Chemical Co., St. 
Louis, MO) was dissolved  in water or in 0.01 M acetic acid. The 
cereal protein was partially digested with pepsin and trypsin (Sigma 
Chemical Co.) largely according to Frazer et al. (15). Flours used 
were from the wheat cultivars Kolibri, Yamhill, Scout 66, Chey- 
enne, Folke, and Tjalve; the blended wheat preparations Canadian 
Western Red Spring, Dark  Northern Spring, Northern  Spring, 
Canadian Hard Winter; or trade (in Norway)-blended wheat, rye, 
barley, and oat. As control antigens, not related to cereals, we used 
purified protein derivate of Mycobacteriura tuberculosis (provided  by 
the National Institute of Public Health, Oslo, Norway), sonicated 
M. tuberculosis (strain H37Ra, provided by Dr. Oftung, The Nor- 
wegian  Radium  Hospital,  Oslo,  Norway),  or  streptokinase 
(Behringwerke, Marburg, Germany). Seven overlapping synthetic 
peptides  covering the  NH2-terminal region  (residue  1-58) of 
ot-gliadin (16-18) were synthesized as described  in detail elsewhere 
(Gjertsen H. A., K. E. A. Lundin, L. M. Sollid, J. A. Eriksen, 
and E. Thorsby, manuscript submitted for publication). The pep- 
tide sequences  were (one letter code)  p14: VRVPVPQLQPQNPSQ- 
QQPQ; p15: QNPSQQQPQEQVPLVQQQ; p16: QVPLVQQQQ- 
FLGQQQPFPPQ;  p19: LGQQQPFPPQQPYPQPQPF;  p209: 
FPGQQQPFPPQQPYPQPQPF; p211: FPGQQQQFPPQQPYP- 
QPQPF; and p62: QPYPQPQPFPSQQPYLQL. 
Ex Vivo Gluten Stimulation of  Biopsies.  Four to six biopsy speci- 
mens were taken by upper gastrointestinal endoscopy obtaining 
biopsies from the distal duodenum. Biopsies from treated CD pa- 
tients on a gluten-free  diet were challenged  for "~18 h with 5 mg/ml 
of a peptic/tryptic digest of commercial gluten (ICN Nutritional 
Biochemicals) in an organ culture chamber at 37~  with 5% CO2 
and 95% O2 at 1 bar pressure in RPMI 1640 (Gibco, Paisley, Scot- 
land) containing 20% inactivated, pooled human serum and anti- 
biotics (13). This gluten challenge step was not done for biopsies 
from individuals on a gluten-containing diet. The biopsies were 
cut in pieces and digested enzymatically with I mg/ml coUagenase 
A (Boehringer Mannheim, Mannheim, Germany) at 370C. Cells 
liberated from the biopsy fragments were harvested after 30 min, 
60 rain, and in one case, 120 min by filtration through a nylon 
filter (mesh width, 200/~m) and named according to the patient 
code and duration of  coUagenase treatment (i.e., CD281 30; etc.). 
T Cell Lines and T Cell Clones (TCC).  Activated  T cells were 
immunomagnetically isolated using Dynabeads (M-450; Dynal, 
Oslo, Norway) coated with an antibody to CD25 (Amersham In- 
ternational, Amersham, Bucks, UK), as described elsewhere (19, 
20). To the cell suspension from three to five  biopsies, 100/~1 beads 
of a 0.1 mg/ml solution was used. Positively selected cells were 
resuspended immediately in 200/zl of a suspension of 2 x  10  s au- 
tologous, irradiated  PBMC in complete medium (CM: RPMI 1640 
with 15% pooled, inactivated human serum and penicillin-strep- 
tomycin) and 5 U/ml rlL-2 (Amersham International). This cell 
suspension was transferred to one well of a flat-bottomed 96-well 
plate and grown for 1 wk. Cultures were thereafter restimulated 
weekly with autologous, irradiated PBMC, 1/zg/ml PHA (Well- 
come, Dartford, UK) and 5 U/ml IL-2. T cell lines isolated from 
biopsies from individuals on a gluten-containing diet were split 
into two subcultures, one which received gluten and one which 
received PHA. In both cases, autologous, irradiated PBMC were 
also here used as APC in the presence of 5 U/ml II.-2. For some 
of the T  cell lines, TCC were established by limiting dilution 
(0.3-0.5 cells/well) in 20-/~1 wells (Terasaki; Nunc, Roskilde, Den- 
mark), using 104 irradiated PBMC, 1 #g/ml PHA, and 5 U/ml 
IL-2. Growing TCC were transferred to 96-well plates and later 
to 24-well plates (Costar Corp., Cambridge, MA), also in these 
cases with weekly restimulation with PHA, PBMC, and Ib2. TCC 
were screened for reactivity and cryopreserved  in the vapor phase 
of liquid N2. 
Phenotyping ofT Cells.  Phenotyping ofT cells for the markers 
CD2, CD3, CD4, CD8, and TCR-a//3 was done by FACS  |  anal- 
ysis (FACSean  |  Becton Dickinson & Co., Palo Alto, CA) or by a 
rosette-forming  assay  using antibody-coated  Dynabcads  M-450 (21). 
Proliferative  Assays and Inhibition Studies.  Proliferative  assays  were 
performed in 0.2 ml CM on 96-weU round-bottomed plates using 
2 x  104 T cells stimulated in triplicates with either 5 x  104 EBV- 
transformed B lymphoblastoid cell lines (B-LCL;  irradiated 10,000 
tad) or 5-10  x  104 PBMC (3,000 tad) in the presence or absence 
of antigen. Peptic-tryptic digests of cereal proteins were used at 
1-2 mg/ml, synthetic peptides at 50 #M. APC were usually prein- 
cubated overnight with antigen, as this was shown to enhance the 
proliferative  response of the T cells (data not shown). Cultures were 
pulsed with [3H]thymidine  after ~48 h, and harvested 18 h there- 
after. APC used were either HLA homozygous B-I.CL distributed 
during the 10th and 11th International Histocompatihility Work- 
shops (IHWS) (22, 23), or PBMC or B-LCL from local CD pa- 
tients or healthy controls (4, 5). In inhibition assays  with anti-HLA 
mAb, APC were preincubated with gluten and mAb before addi- 
tion of the T cells, mAb used for inhibition studies were W6/32, 
anti-HLA class I monomorphic (American Type Culture Collec- 
tion [ATCC], Rockville,  MD); L243, anti-HLA-DK monomorphic 
(ATCC); B8.11, anti-HLA-DR  monomorphic  (a  gift from  B. 
Malissen, Centre d'Immunologie, Marseille, France); GSP4.1: anti- 
HLA-DR monomorphic (a gift from J. Hansen, Fred Hutchinson 
Cancer Research Center, Seattle, WA); SPV-L3, anti-HLA-DQ 
monomorphic (a gift from H. Spits, DNAX Research Institute, 
Palo Alto, CA); FN81, anti-HLA-DQ monomorphic (a gift from 
S. Fundernd, The Norwegian Radium Hospital, Oslo, Norway); 
2.12.E.11, anti-HLA-DQ2 (a gift from H. Viken, our institute); 
XIII 358.4, anti-HLA-DQ2, (a gift from C. Mazzilli, University 
of Rome, Rome, Italy); and B7/21, anti-HLA-DP monomorphic 
(a gift from F. Bach, University of Minnesota Hospital, Minne- 
apolis, MN). 
HLA.DQB Transacted  B Celk Transfection  with HLA-DQBI*0201 
cDNA was performed essentially as described elsewhere (24, and 
Paulsen, G. et al., manuscript in preparation). In short, DQBI*0201 
cDNA (a gift from Janet Lee, Sloan-Kettering Institute for Cancer 
Research, New York) from the DR7DQ2 + cell line BH (10th 
IHWS, No. 9046) was transfected by a retroviral method into the 
DR5DQ7 + cell line Sweig007 (10th IHWS,  No. 9037), which 
carries  DQAI*0501  and  DQBI*0301. Transfected cells were 
propagated in selective medium for several cycles to ensure stable 
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DQ(BI*0201)  was shown by FACS analysis  |  (Becton Dickinson 
& Co.) using the mAb XIII 358.4. 
TCR Sequencing.  TCR c~ and  B gene  sequencing  was per- 
formed using modified PCR techniques  as described elsewhere 
(25).  At least three  M13 plaques for each TCR gene were se- 
quenced,  except that,  because of a PCR slippage problem,  we 
were  only  able  to  find  one  M13  plaque  which  included  the 
CDR3ol of the V0~22  + transcript  of TCC  1.27. 
Results 
Growth and Gluten Reactivity ofT Cells  from Small Intestinal 
Biopsies.  Activated, CD25 + T cells were positively selected 
from  small  intestinal  biopsies from  13 individuals.  T  cell 
growth was observed in  11 of the 13 cases,  and the T  cell 
lines were tested after 2-3 wk. T  cell lines could be estab- 
lished from biopsies from four of the six patients with treated 
CD,  where positive selection of activated,  CD25 + T  cells 
was done with ex vivo challenge with gluten. Of these four, 
gluten-specific responses were observed in T  cell lines from 
three  individuals,  two  showed  strong  responses  and  one 
showed a weak response which was not investigated further 
(data not shown). The small intestinal morphology and the 
subsequent gluten  reactivity of biopsy-derived T  cell lines 
are depicted in Table 1. A weak gluten-specific proliferative 
response was observed for one T cell line from one untreated 
CD patient,  but not from the other untreated CD patient 
or the five patient controls (Table 2, and data not shown). 
Polyclonal T  Cell Recognition of Gluten and Preferential Re- 
striction by the CD-associated DQ Heterodimer.  Three T  cell 
lines  (termed  CD281  30',  CD280  60',  and  CD280  120') 
showing reactivity towards gluten were studied in mAb in- 
hibition  experiments.  CD280 is HLA-DR3,6,  DQ1,2 and 
CD281 is HLA-DR3, DQ1,2. mAb inhibition studies showed 
a complete inhibition of the CD281 30' and CD280 120' lines 
by anti-DQ mAb, whereas the response of the CD280 60' 
line was partly inhibited by anti-DR, partly by anti-DQ mAb 
(Fig.  1). 
We next stimulated the lines from CD280 and CD281 with 
gluten, using cells from a panel of allogeneic donors as APC. 
Table  2.  Proliferative  Responses of T Cell Lines Directly Isolated 
from Untreated Patients and Controls 
CD294"  CD289  CD297  CD290 
DR3,6  DR3,6  DtL3,7  DR2,4 
DQ1,2  DQ1,2  DQ2  DQ1,3 
CD pt.  CD pt.  Contr.  Contr. 
T cells alone  0.1  0.1  0.7  0.1 
APC alone  1.6  0.2  1.5  0.4 
T + APC  1.6  0.2  1.8  0.4 
T + APC + gluten  3.1  0.2  1.2  0.3 
T  + APC + PHA + IL-2  51.6  19.0  33.6  40.4 
Values show mean cpm ( x  10 -3) of triplicate cultures. SD was usually 
<10%.  Positive values are given in boldface. 
Since only weak responses were seen with PBMC as APC 
(possibly because of the low expression of HLA-DQ on such 
cells)  we used B-LCL. Some results are given in Fig.  2.  In 
some cases, weak or moderate alloresponses to the APC in 
the absence of gluten was observed, but strong gluten-specific 
proliferative responses were always observed using B-I.CL from 
donors being DR3,DQ2, i.e., carrying the DQAI*0501 and 
DQBI*0201 genes in c/s position. When instead APC were 
used from a donor being DRS,DQ7/DR7,DQ2,  i.e.,  car- 
tying the DQAI*0501 and DQBI*0201 genes in trans posi- 
tion, a weak gluten-specific response of the CD280 120' frac- 
tion was seen. However, for the two other polyclonal T cell 
lines, weak gluten-specific  responses were also seen using APC 
from some donors not being DR3,DQ2.  From the results 
of the antibody inhibition experiments and the panel studies 
we conclude that  a preponderance  of the  small intestinal- 
derived gluten-reactive T  cells tested were restricted by the 
CD-associated DQ heterodimer. 
The antigen specificity of the T  cell lines was then inves- 
tigated (Table 3, and data not shown). They recognized gluten 
from a variety of wheat formulations,  but not rye and not 
Table  1.  Histology of the Small Intestinal Biopsies  from  Treated Patients 
Morphology  Cell density  Gluten  reactivity 
CD280  Partial villous athrophy  Increase of IEL and LPL  Yes 
CD281  Partial villous athrophy  Increase of IEL and LPL  Yes 
CD286  Minor villous changes  Normal IEL and LPL  No 
CD287  No pathological  changes  Normal IEL and LPL  No T  cell growth 
CD288  Partial villous athrophy  Normal IEL,  slight  increase of LPL  No T  cell growth 
CD295  Partial villous athrophy  Increase of IEL and LPL  Yes (weak) 
The cell density of intraepithelial lymphocytes (IEL) and lamina propria lymphocytes (LPL) was judged by light microscopy on H-E stained sections. 
Also indicated is gluten reactivity of T  cell lines derived from the biopsies. 
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Figure 1.  mAb inhibition  of gluten-specific  responses 
of  polyclonal  T cell  lines  from  the small  intestinal  mucosa 
suggested preferential  HLA-DQ  restriction. T cell lines 
shown are the 30' fraction  from patient CD281, and the 
60' and 120' fractions  from patient CD280. Gluten  was 
presented by allogeneic  DR3,DQ2  + B-LCL  to the T cell 
lines. The mAb L243 (anti-DR)  or SPV-L3 (anti-DQ)  were 
used as 1:500 dilutions  of ascites. Bars show mean cpm 
of triplicate cultures. (T sF) T cells alone. 
pepsin-trypsin, which had also been present during the pri- 
mary ex vivo stimulation of the biopsies.  The T  cell lines 
all recognized the gliadin moiety of gluten. No responses 
to control antigens not related to cereals were observed. 
Isolation of Gluten-specific TCC.  To investigate the fine 
specificity of individual T  cells, we raised  TCC.  All TCC 
were screened for reactivity towards gluten presented by B-LCL 
being DR3,DQ2, and tested in mAb inhibition assays using 
anti-DR and anti-DQ mAb. A varying proportion of TCC 
from each cell line showed gluten reactivity. 7 of 80 TCC 
from the CD281 30' fraction (e.g., TCC 1.27, 1.50, and 1.63) 
and 4 of 80 TCC (e.g., TCC 5.14 and 5.48) from the CD280 
60' fraction were strictly gluten reactive. Other TCC showed 
a complex pattern, partly alloreactive, partly gluten reactive, 
and were uniformly inhibited by anti-DR, but not by anti- 
DQ mAb. Gluten specificity was observed for 76 of 83 TCC 
from the CD280 120' fraction (e.g.,  TCC 4.19).  However, 
most or all these TCC appeared  to be sister clones (based 
on sequencing of the TCR and/or reactivity staphylococcal 
exotoxins, data not shown). Importantly, all strict gluten- 
reactive TCC were HLA-DQ restricted, with one exception. 
Gluten-specific TCC Were Restricted by the CD-associated DQ 
Heterodim~  Some TCC with strict gluten-specific responses 
were  further  analyzed,  all  carrying  the  CD2 +,  CD3 +, 
CD4 +,  CDS-,  TCR-c~//~ +  phenotype.  Three  different 
kinds of experiments were performed. 
First, we performed inhibition studies using a panel of anti- 
HLA mAb to inhibit the response to gluten in the presence 
of APC being DR3,DQ2.  For all TCC except  one, mAb 
against HLA class I, HLA-DR, or HLA-DP did not inhibit 
the gluten-specific responses  (data not shown). In contrast, 
a range of HLA-DQ2-reactive mAb inhibited the reactivity 
DQA1 DQB1 
APC  o6ol  o~ol  CD281 30'  CD280 60' 
None 
CD114  DR3DQ2  +  + 
RQ DR3DQ2  N.d.  N.d. 
CD280 DR3DQ2/ N.d.  N.d. 
DR6DQ1 
CD036  DRSDQ7/  +  + 
DR7DQ2 
9004 DRtDQ5 
9016 DR16DQ7  "1" 
9018 DR3DQ2  +  + 
9019 DR3DQ2  +  + 
9021 DR3DQ4 
9031 DR4DQ8 
9037 DR5DQ7  + 
9O49 DR7DQ2  + 
9066 DRODQ6 
9O7O DRSDQ7 
CD280  120' 
o  '  ~  ' 
-  '  '  ,  i  ,  , 
40  ~, 
L. 
mm 
Mean cpm x 10  "3 
Figure  2.  APC from donors being DR3, 
DQ2 preferentiaUy  induced  a gluten-specific  re- 
sponse of  the T cell  lines  tested  (same  as in Fig. 
1). The APC were  either  local  B-LCL  (CDl14, 
RG, CD280, CD036) or homozygous  B-LCL 
distributed during the 10th or 11th IHWS. 
(Hatched  bars) T cell  responses (mean  of tripli- 
cate cultures) in the presence of APC alone. 
(Solid  bars) T cell  responses  to gluten  plus APC. 
(+, -) Presence  or absence  of  the CD-associated 
DQAI*0501 and DQBI*0201 genes. (NJ.) Not 
determined by genomic typing. 
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CD281  CD280 
30'  120'  4.19  5.14  5.48  1.27 
T  cells alone  0,1  0,0  0,0  0,0  0,0  0,0 
APC alone  1,0  1,0  0,6  0,7  0,7  0,7 
T+APC  1,8  1,4  0,8  0,7  0,8  0,7 
T + APC + ICN  24,6  37,2  43,2  26,8  13,3  18,0 
T + APC + Sigma  21,7  12,4  23,5  15,8  13,5  15,5 
T + APC + CWRS  17,4  29,2  27,1  7,7  12,5  10,7 
T + APC + NS  ND  ND  7,7  8,8  9,6  4,6 
T + APC + CHW  ND  ND  5,1  7,2  7,4  3,7 
T + APC + Kolibri  17,8  23,8  15,9  3,5  9,1  8,1 
T + APC + Rye  4,2  1,4  0,6  0,7  1,5  0,7 
T + APC + Barley  ND  1,7  0,9  0,7  1,9  0,7 
T + APC + Oat  ND  ND  0,7  0,7  0,8  0,7 
T + APC + p14  1,8  1,1  0,7  0,7  0,9  0,6 
T + APC + p15  1,6  1,3  0,8  0,7  0,9  0,6 
T + APC + p16  ND  1,3  0,6  0,7  0,8  0,6 
T + APC + p19  1,6  1,1  0,6  0,7  1,0  0,6 
T + APC + p209  1,7  1,2  0,6  0,6  0,9  0,6 
T + APC + p211  1,8  1,2  0,6  0,6  1,0  0,7 
T + APC + p62  1,6  1,3  0,8  0,7  1,0  0,7 
Values show mean cpm ( x 10  3) of triplicate cultures. SD was usually <10%. Positive values are given in boldface, antigens used were proteins 
from various cereals, or synthetic peptides covering residues 1-58 from ot-gliadin. ICN, Sigma, CWRS, NS, CHW, and Kolibri denote various 
wheat varieties, as outlined in Materials and Methods. 
of these TCC. Only one gluten-specific TCC (5.26) was in- 
hibited by an anti-DR mAb, but its poor expansion poten- 
tial made full characterization  impossible. 
Second, we performed panel studies using a large panel 
of HLA homozygous 10th and 11th IHWS B-LCL as APC. 
Some results for four of the TCC appear in Fig. 3. Five of 
five B-LCL homozygous for the HLA-DR3DQ2 haplotype 
(carrying DQAI*0501 and DQBI*0201 genes in c/s position) 
induced strong gluten-specific  responses, whereas by and large, 
this was not  observed for B-LCL not carrying  this haplo- 
type. No APC being DR5,DQ7 (carrying DQAI*0501 but 
not DQBI*0201) induced a gluten-specific response, whereas 
APC  being  DR7,DQ2  (carrying  DQBI*0201  but  not 
DQAI*0501) induced a weak gluten-specific response of TCC 
4.19, but not the other TCC. We also used more than 25 
different B-LCL from healthy individuals and CD patients 
as APC (Fig.  3, Table 4, and data not shown). Also in this 
case,  B-LCL from  all donors  being DR3,DQ2  induced  a 
gluten-specific response of the TCC. 
B-LCL from a family involving a DR5DQ7/DR7DQ2 
heterozygous CD patient (5) who thus carry the DQAI*0501 
and DQBI*0201  genes in trans position,  were then inves- 
tigated. Three of the TCC (5.14, 5.48, and 1.63) recognized 
gluten presented by B-LCL from the CD patient,  but not 
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from  the  father  (DR4DQ7/DR5DQ7)  or  the  mother 
(DR7DQ2/DR8DQ4) (Table 4, and data not shown). This 
demonstrates that these TCC were abl~ to recognize gluten 
when presented by the DQ(ot1*0501,/31*0201) heterodimer 
encoded by genes in  the trans position. 
Third, B-LCL being DR5,DQ7 (carrying DQA1*0501 and 
DQBI*0301) which had been transfected with a DQBI*0201 
gene, was used as APC. This transfectant expressed the en- 
dogenous DQ(c~1"0501,/31"0301) as well as a DQ(oA*0501, 
/31"0201) heterodimer.  All TCC responded to gluten presented 
by the transfected B-LCL, but not when presented by the 
original  untransfected  B-LCL (Fig.  4). 
TCC Recognized Gluten  from a Variety of Wheat Cultivars, 
but Not  from other Cereals.  All TCC recognized most of the 
wheat preparations used, although some formulations were 
more stimulatory than others (Table 3). All gluten-specific 
TCC recognized the gliadin moiety of gluten.  In contrast, 
proteins from rye, barley,  and oat were not recognized by 
any of the TCC tested (Table 3). We then examined whether 
the TCC could respond to any of a panel of seven overlap- 
ping  peptides  covering  the  NH2-terminal  58  amino  acid 
residues of ot-gliadin. Neither the T cell lines nor the clones 
tested showed any reactivity towards these peptides (Table 3). 
Diversity ofTCR Usagg  TCR usage of the gliadin-specific DQ,~I  DQB1 
APC  o8ol  oaol  4.19  5.14  1.27  1.50 
None 
CDl14 DR3DQ2  +  + 
8O DR3DQ2/ 
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9019 DR3DQ2  +  + 
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gO87 DR3DQ2  +  + 
9O88 DR3DQ2  +  + 
9O27 DPADQ7 
9031  DPADQ8 
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9038 DR5DQ7  + 
9046 DR7DQ2  -t- 
9047 DR7DQ2  + 
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Figure  3.  APC from donors carrying both 
DQAI*0501 and DQBI*0201 induce a gluten- 
specific response of the TCC tested.  Legends 
and data presentation as in Fig. 2. (N.t.) Not 
tested in this experiment. 
DQA1  DQB1 
APC  0501  0201 
None 
9037 DRSDQ7  +  - 
gO37DQB  +  + 
RG DR3DQ2  +  + 
None 
9037 DR5DQ7  + 
9O37DQB  +  + 
RN DR3DQ2  +  + 
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Figure 4.  The gluten-specific TCC recognized gluten 
presented by  a  transfectant  expressing  DQ(o~1"0501, 
/~1"0201). The 10th IHWS B-LCL No. 9037 (carrying 
DQAI*0501  and  DQBI*0301)  was  transfected  with 
DQBI*0201, giving the transfectant 9037DQB. (RG and 
RN) Local B-I_CL  carrying DQAI"0501 and DQBI*0201. 
(Hatched bars) T  cell responses in the presence of APC 
alone. (Solid bars) T cell responses to gluten in the pres- 
ence  of APC  and  show  mean  incremental  cpm  (ex- 
perimental mean value  -  mean of [3H]thymidine  incor- 
poration of APC alone). 
192  Gliadin-specific,  HLA-DQ-restricted Mucosal T  Cells in Celiac Disease Table  4.  HLA-DQ (or 1 "0501,/3 1 "020I) May Present Gluten to  TCC When It Is Encoded in Both Cis and Tram 
APC  TCC response 
DQA1  DQB1  5.14  5.48 
HLA-DR  0501  0201  No Ag  With Ag  No Ag  With Ag  B-LCL alone 
CD280 (Auto)  DR3/6  ND  ND  0.2  _+  0  11.2  _+  2.4  0.1  _+  0  11.1  _+  2.1  0.1  _+ 0 
CDl14  DtL3/3  +  +  (cis)  1.8  _+  0  16.8  _+  1.5  1.3  _+ 0.3  35.0  +_  2.6  1.0  _+  0.1 
CD052  DR5/7  +  +  (tram)  0.6  +_ 0.2  3.9  +_ 0.6  0.5  +_ 0  13.7  +_ 0.3  0.4  _+ 0.1 
CD268  DR4/5  +  -  0,7  +  0.1  1.1  _+  0.7  0.7  +  0.1  1.4  _+  0.5  0.7  +  0 
CD225  DR7/8  -  +  0.7  +_  0.3  0.5  _+ 0  0.6  _+  0  1.7  _+  0.1  0.5  _+  0 
No.  9038  DtL5/5  +  -  0.3  +  0  0.3  _+  0  0.4  +  0.1  0.7  _+  0.4  0.3  +_  0 
No.  9047  DR7/7  -  +  0.5  +  0.1  0.5  _+  0.1  0.5  _+  0  0.5  +  0.1  0.4  _+  0.1 
The proliferative response to a peptic-tryptic digest of gluten (2 mg/ml) was investigated. Irradiated B-LCL from local donors or HLA homozygous 
10th IHWS B-LCL were used as APC. CD052 denotes a CD patient. CD268 and CD225 denotes her healthy parents (5). Values show mean cpm 
( x 10 -3) of triplicate cultures _+ SD. Positive values are given in boldface. Only the presence or absence of DQAI"0501 and DQBI*0201 is indi- 
cated. Cis and trans denotes the chromosomal location of these genes as carried by the given APC. 
TCC was examined by sequencing of TCR c~ and 3  genes. 
The TCC carried a number of different Vcr and V3 segments 
(Table 5).  Two TCC carried two functionally rearranged o~ 
chain genes, it is not known which were expressed. Vol6.2, 
Vo~12.1, Vol22.1, and V/36.7 were all found twice. Apart from 
this, it was evident that a wide range of T cells with differing 
TCR variable segments were able to recognize gluten presented 
by DQ2. We also compared the CDR3 (V-(D)-J) junction 
of the TCR,  and found different  sequences  here  also. 
Discussion 
This report shows that gluten-reactive T  cells may be iso- 
lated from the small intestinal mucosa of CD patients.  The 
major proportion of these T  cells was found to be restricted 
by the CD-associated HLA-DQ(c~I*0501,BI*0201) hetero- 
dimer. 
Gluten-specific proliferative  responses were found in T cell 
lines established from ex vivo gluten-stimulated biopsies from 
treated CD patients and propagated in the absence of gluten. 
Of the six treated patients tested, we succeeded in establishing 
gluten-reactive T cell lines from three individuals. It may be 
relevant that those three individuals had an irregular small 
intestinal  morphology  (they  had not  fully recovered  on a 
presumptive gluten-free diet), whereas the three patients from 
whom we were unable to establish gluten-specific T cell lines 
had either a normal or nearly normal small intestinal mor- 
phology. Most recently, we investigated T cells isolated from 
biopsies from a CD patient being not DIL3, DQ2, but rather 
DR4,DQS.  We and others (26, 27) have found that the few 
Table  5.  TCR  Usage of Gluten-specific TCC Examined 
TCC  TCR-o~  TCR-B 
4.19  Vod2.1 
5.14  Va6.2 
5.48  Val7.1 
Vod2.1 
1.27  Vc~6.2 
Va22.1 
1.50  Vot20.1 
1.63  V~x22.1 
CALSEKGGYQKVTFG  Jc~02 (AG212)  V/~1.2 
CAMRDLKTSYDKVIFG  Jc~MTC5  V/~8.1 
CALSEAGANSKLTFG  Jo~07  V/~6.7b 
CAAIHGGSQGNLIFG  Jc~06 
CAMREGQAGNQAGTALIFG  J~S  VB20.1 
CALSDLTDSWGKLQFG  Jc~RB2 
CLVGGNSGGGADGLTFG  Jc~W  VB6.7a 
CALSDASQGGSEKLVFG  Jc~AC9  VB22.1 
CASSVSPIGPEQYFG  J/~2.7 
CASR.SLEWGIGEGQPQHFG  JB1.5 
CASSILQGGDTQYFG  JB2.3 
CAWSTTGWDTGELFFG  J~2.2 
CASSFRALDVNEQFFG  J/~2.1 
CATNQRAYNEQFFFG  JB2.1 
TCR. genes were sequenced using a modified PCR technique (25). The CDIL3 region sequences are given from the conserved cysteine residues in 
Vo~ and VB to the conserved FG pair of residues in Ja and JB. The nomenclature of V~, Jol, V/3, and JB is according to Obata and Kashiwagi (50). 
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instead carry DQ(o~1"0301,~1"0302) (DQ8). This patient had 
an irregular small intestinal morphology, and also in this case 
were gluten-specific responses found, but restricted by HLA- 
DQ8 (Lundin, K. E. A., et al., manuscript in preparation). 
Thus, an increased number of T  cells in the biopsies  may 
well facilitate establishment of gluten-specific T cell lines. In 
keeping with this notion, the CD biopsy specimens showing 
higher frequencies of CD25 § T cells following ex vivo chal- 
lenge with gluten (13) do also have subtle morphological 
changes (Halstensen, T. S., et al.,  unpublished results). 
In one case, a weak gluten-specific response was also found 
for a T cell line from an untreated patient. The main differ- 
ence in the handling of biopsies from treated and untreated 
patients is that biopsies from individuals on a gluten-containing 
diet were not challenged, since many of the T cells in the 
untreated lesion already are activated.  It is conceivable that 
establishment of gluten-specific T cell lines has a better chance 
of success using biopsies from treated patients, since the in- 
tense immunological activation in ongoing lesions may also 
harbor many T  cells not specific for gluten, but activated 
nonspecifically. Findings compatible with this view have been 
reported from  studies of allograft rejection (28)  and  ex- 
perimental allergic encephalomyelitis in rats (29). 
Another explanation for our failure to detect strong prolifer- 
ative gluten-specific responses in T cell lines from the estab- 
lished lesions may be that gluten-specific T cells could have 
lost their proliferative, antigen-responsive potential, but still 
could provide other T cell functions. Such findings have been 
done for gut-associated T lymphocytes in bacterial infections 
in primates (30).  Further,  activated  CD4 + T  cells in the 
lamina propria of untreated CD patients, although they ex- 
press the CD25 activation antigen, do not express the Ki-67 
marker, suggesting that cell division does not take place (31). 
Evidence indicates  that  CD4 §  T  cells  in  the  lamina 
propria play an important role in the development of the celiac 
lesion (2, 3, 8, 13, 32, 33). However, the antigen specificity 
and HLA restriction of such T cells have previously not been 
established. The gluten-specific, HLA-DQ-restricted T cells 
obtained in this study were most probably derived from the 
lamina propria, because lamina propria CD4 +, TCR-cU/~ + 
T cells are specifically stimulated to express CD25 by gluten 
challenge of biopsies ex vivo (13). Our T cells were first posi- 
tively selected for their CD25 expression  and later shown 
to be CD4 +,  TCR-cr  +. Second, there is strong expres- 
sion of DQ molecules on lamina propria APC, but not on 
epithelial cells  (34),  and our T  cells were predominantly 
HLA-DQ restricted. Moreover,  the T  cells are most likely 
relevant for CD since only T cells in small intestinal biopsies 
from CD patients but not from healthy individuals, can be 
induced to express CD25 by gluten challenge (13). 
The HLA association of CD is well-established and is pri- 
marily conferred by the DQ(otl*0501,/~1*0201) heterodimer 
(4-7). By using an extensive panel of HLA homozygous or 
heterozygous B-LCL as APC, we found that the gluten-specific 
responses of the T cells studied were restricted by the CD- 
associated DQ(otl*0501,/$1*0201) heterodimer. Using TCC, 
gluten-specific responses were seen when the APC expressed 
this molecule encoded by DQAI*0501 and DQBI*0201 genes 
in c/s or in trans position. These studies are in agreement with 
our  previous studies using alloreactive  TCC  recognizing 
DQ(c~l*0501,Bl*0201)  (5).  Also in the present study, we 
observed weaker responses of the TCC when the restricting 
DQ(cr  heterodimer was encoded by genes 
in trans than in c/s position. The reason for this could be lower 
density of the tram-encoded  molecule, since this appears to 
correlate  with T  cell response (35). 
The DQ(~l*O501,Bl*O201)-restricted,  gluten-specific  T 
cells all carried diverse TCR. Thus, we were unable to dem- 
onstrate a predominant TCR usage by such T cells, in con- 
trast to what has been found in experimental models of MHC 
class II-associated diseases in rodents (36). Interestingly, studies 
so far have failed to show any association between germline 
TCR polymorphisms and susceptibility to CD (7, 37). 
The diversity of the TCR used may indicate that the in- 
volved T ceils may recognize not a single but rather a range 
of gliadin peptides. Wheat gliadins consist of o~/fl,  %  and 
co gliadins, all of which may cause disease (38). Considerable 
interest has been paid to peptides from the NH2-terminal  re- 
gion of cx-gliadin, since they have been shown to sustain the 
pathology of the established CD lesion using organ culture 
assays with biopsies  from untreated CD patients (39,  40). 
Interestingly, we have recently defined a T  cell epitope in 
this region with DQ(oll*0501,fll*0201)-restricted T cells from 
the peripheral blood of a CD patient (Gjertsen et al., manu- 
script submitted for publication). However, neither the TCC 
nor the TCC lines described here showed reactivity to any 
of the seven peptides tested.  At least two possible explana- 
tions for this finding are apparent. First, since there is genetic 
variability between c~-gliadins (16-18), these findings do not 
allow us to definitively exclude that the T cells actually recog- 
nize peptides from this region. Second,  although disease- 
relevant epitopes can be found in the NH2-terminal region 
of ol-gliadin (39, 40),  other regions in both cx-gliadin (39, 
41) and other gliadins have been suggested to be implicated 
in the disease (38,  42-44). 
Not only wheat, but also rye and barley, and possibly also 
oat, have been considered capable of perpetuating CD (1). 
However, whereas the prolamins of wheat and the other cereals 
have many similarities, their sequences are generally not iden- 
tical (45). This may explain why our T ceils did not recog- 
nize other cereals than wheat. 
One of the major uncertainties regarding HLA-associated 
diseases is the level at which the HLA association  is oper- 
ating (46-48). It has been argued that HLA-DQ molecules 
should be mainly responsible  for shaping the T  cell reper- 
toire rather than presenting antigen to mature T cells (48). 
The present report strongly suggests that HLA-DQ mole- 
cules can efficiently present antigenic peptides to T cells in 
the target organs. With regard to CD, it is conceivable that 
gluten-specific, HLA-DQ-restricted T cells in situ secrete lym- 
phokines which cause the immunopathology. At least two 
different not mutually exclusive pathways could be involved 
in this process. IFN-'y may cause death of mucosal epithelial 
194  Gliadin-specific,  HLA-DQ-restricted Mucosal T Cells in Celiac Disease cells (49),  and this cytokine could be found in supernatants 
after activation of the TCC studied (Nilsen, E. M. et al., 
unpublished results). Alternatively, activated T  cells could 
secrete  an unknown lymphokine causing crypt cell hyper- 
plasia (8, 33). Thus, one possible mechanism behind the DQ 
association in CD may be preferential presentation of gluten 
to T cells in the small intestine by the disease susceptibility 
DQ(c~l*0501d31*0201) molecule itself. Important questions 
which remain to be answered are why this particular DQ 
molecule may serve this function and why not all individuals 
carrying this particular DQ molecule develop  CD. 
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